← Back to Search

Participatory Systems Engagement for Addiction and Mental Health Care

N/A
Waitlist Available
Led By Lindsey E Zimmerman, PhD
Research Sponsored by Palo Alto Veterans Institute for Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-/post- 12-month period average of evidence-based practice reach (24 months total observation)
Awards & highlights

Summary

This trial tests if a new method of engaging patients, providers, and policy makers in addiction and mental health care (participatory system dynamics) is more effective than status quo approaches.

Who is the study for?
This trial is for VA divisions and outpatient clinics that are below the median in quality for treating depression, PTSD, and opioid use disorder. They must have at least a year's worth of data from 2018 but not be involved in other specific VA improvement programs or scheduled for EHR updates during the study.Check my eligibility
What is being tested?
The trial tests Participatory System Dynamics (PSD), which involves patients, providers, and policymakers to improve care access against standard methods like Audit and Feedback (AF). It aims to see if PSD can enhance treatment reach within veteran healthcare services.See study design
What are the potential side effects?
Since this trial focuses on system dynamics rather than medical treatments, it does not involve direct patient interventions with physical side effects. However, changes in organizational processes could indirectly affect patient care experiences.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-/post- 12-month period average of evidence-based practice reach (24 months total observation)
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-/post- 12-month period average of evidence-based practice reach (24 months total observation) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of combination of prescriptions placed with the VA pharmacy and sessions with a relevant CPT code
Proportion of completed evidence-based practice templates during sessions with a relevant CPT code
Proportion of patients diagnosed with alcohol use disorder, depression, opioid use disorder, or PTSD who meet evidence-based psychotherapy and pharmacotherapy initiation and course measures divided by total number of patients with these diagnoses
Secondary outcome measures
Degree of acceptability of intervention assessed by the Acceptability of Intervention Measure (AIM) [followed by its scale information in the Description]
Degree of appropriateness of intervention assessed by the Intervention Appropriateness Measure (IAM) [followed by its scale information in the Description]
Degree of feasibility of intervention assessed by the Feasibility of Intervention Measure (FIM) [followed by its scale information in the Description]
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Participatory System Dynamics (PSD)Experimental Treatment1 Intervention
12 clinics assigned to PSD
Group II: Audit and Feedback (AF)Experimental Treatment1 Intervention
12 clinics assigned to AF

Find a Location

Who is running the clinical trial?

Palo Alto Veterans Institute for ResearchLead Sponsor
52 Previous Clinical Trials
7,185 Total Patients Enrolled
Lindsey E Zimmerman, PhDPrincipal InvestigatorNational Center for PTSD, Dissemination & Training Division

Media Library

Participatory System Dynamics Clinical Trial Eligibility Overview. Trial Name: NCT04356274 — N/A
Opioid Use Disorder Research Study Groups: Participatory System Dynamics (PSD), Audit and Feedback (AF)
Opioid Use Disorder Clinical Trial 2023: Participatory System Dynamics Highlights & Side Effects. Trial Name: NCT04356274 — N/A
Participatory System Dynamics 2023 Treatment Timeline for Medical Study. Trial Name: NCT04356274 — N/A
Opioid Use Disorder Patient Testimony for trial: Trial Name: NCT04356274 — N/A
~11 spots leftby Aug 2024